SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bitcoin (BTC) is a cryptocurrency launched in 2010. Users are able to generate BTC through the process of mining. Bitcoin has a current supply of 20,111,281. The last known price of Bitcoin is 71,086.72423286 USD and is down -3.89 over the last 24 hours. It is currently trading on 12779 active market(s) with $28,515,435,687.36 traded over the last 24 hours. More information can be found at https://bitcoin.org/.

Bitcoin

Bitcoins sharp selloff and break below key support levels are dominating discussion, with traders pointing to leveraged-long liquidations and broader risk-off pressure across crypto and tech as possible contributors. The community is split between warnings of further downside and calls to buy an oversold dip or watch for support.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Sellas reiterated that topline results from its Phase 3 REGAL trial of GPS in AML are expected in November after the trial reached its required event milestone, drawing attention to the pending binary readout. Traders are broadly excited about the prospect of positive data and a short squeeze, while speculation about a leak or buyout remains unconfirmed and skeptics stress that results have not been released and the trial outcome is uncertain.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

A widespread Microsoft 365 outage disrupted Outlook, Teams, Copilot and other services, prompting complaints about work interruptions and concern that the prolonged disruption could damage trust or pressure the stock. Some traders speculated about a cyberattack, but the cause was not confirmed, and others questioned why shares held relatively steady.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MSCIs decision to remove Strategy from its indexes is fueling concerns about passive fund selling, while Bitcoins decline adds pressure to the stock. Traders debate whether the potential outflows are already priced in and whether the exclusion will materially weaken Strategys Bitcoin-linked financing model.

XRP (XRP) is a cryptocurrency . XRP has a current supply of 99,985,583,260 with 63,516,606,953 in circulation. The last known price of XRP is 1.03439229 USD and is down -2.16 over the last 24 hours. It is currently trading on 1895 active market(s) with $1,786,076,895.36 traded over the last 24 hours. More information can be found at https://xrpl.org/.

Ripple

XRPs sharp decline toward the $1 support level amid a broader crypto selloff is dominating discussion, with traders pointing to Bitcoin weakness, inflation and rate concerns, and liquidations. Bears warn of further downside and question Ripples ability to provide catalysts, while some holders view the drop as a buying opportunity and continue accumulating.

Zcash (ZEC) is a cryptocurrency . Users are able to generate ZEC through the process of mining. Zcash has a current supply of 16,962,604.07029401. The last known price of Zcash is 956.58767703 USD and is down -2.92 over the last 24 hours. It is currently trading on 670 active market(s) with $828,877,374.43 traded over the last 24 hours. More information can be found at https://z.cash/.

Zcash

Zcashs sharp pullback after a major rally is dominating discussion, with traders debating whether it is a broader crypto-market correction and liquidation flush or a deeper breakdown. Some call the selloff an oversold buying opportunity, while bears point to lost support and continued selling.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Jensen Huangs resignation and Colette Kresss interim appointment have rattled NVDA shares, with traders also debating potential China chip-export scrutiny and the companys reliance on Huangs leadership. The community is split between buying the selloff on confidence in Nvidias AI business and avoiding the stock amid leadership and regulatory uncertainty.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candels planned prostate-cancer BLA filing has been pushed to mid-2027 amid FDA discussions and assay refinement, prompting a sharp selloff and criticism of managements communication and credibility. Some traders see the delay as a manufacturing and regulatory hurdle rather than a problem with the clinical data, while others remain concerned about execution and the longer wait.

Bitmine Immersion Technologies, Inc. is a technology company focused on acquiring, holding, and actively managing ETH as its primary treasury reserve asset. It prioritizes digital ecosystem services, such as consultancy and advisory works. The company was founded on August 16, 1995 and is headquartered in Las Vegas, NV.

BitMine Immersion Technologies Inc

Weakness in Ethereum and broader crypto-linked stocks is weighing on BitMine, while traders also criticize its underperformance and question managements spending, transparency, and buybacks. Some see the stocks discount to its crypto holdings as a buying opportunity, but bearish posts argue falling ETH prices can overwhelm any support from repurchases.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Coinbase is under pressure as Bitcoin and broader crypto markets sell off, with traders highlighting COINs repeated new lows and weak performance even when Bitcoin stabilizes. Bearish calls dominate, though some see the decline as oversold and are buying the dip.

statis crypto Watchlist

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Brief India: Aditya Birla Fashion & Retail Ltd. - New Businesses Offset Cyclical Softness; Maintain HOLD and more

In this briefing: Aditya Birla Fashion & Retail Ltd. - New Businesses Offset Cyclical Softness; Maintain HOLD PFC - REC: Assessing the Potential Merger and Its Implication for the Shareholders Primer: RPG Life Sciences (RPGL IN) - Feb 2026 Fractal Analytics IPO: Play on Enterprise AI and Analytics, Quality Franchise at Premium Valuation Scales An Apple a Day—Early Signs of a Healthy FY26 1. Aditya Birla Fashion & Retail Ltd. - New Businesses Offset Cyclical Softness; Maintain HOLD Scale building despite demand headwinds: ABFRL posted a steady ~8% YoY revenue increase in Q3FY26, largely driven by strong momentum in its newer growth engines. The TMRW and Luxury segments delivered robust growth of 27% and 29% YoY, respectively, while the Ethnic business expanded 20%. Performance in Pantaloons was skewed by the shift in festive and end-of-season sales to Q2 and Q4. Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only.

Brief Healthcare: Hims & Hers Pushes Diagnostics—But GLP-1 Fallout Looms and more

In this briefing: Hims & Hers Pushes Diagnostics—But GLP-1 Fallout Looms McKesson’s Portfolio Shake-Up: Can Focused Platforms Deliver Faster, Smarter Expansion? GSK’s HIV Strategy Is Shifting Long-Acting—And It Could Redefine the Market Through the 2030s! Novartis’ Next Growth Engine—B-Cell Therapies, Autoimmune Breakthroughs, and Massive Unmet Needs! Primer: RPG Life Sciences (RPGL IN) - Feb 2026 1. Hims & Hers Pushes Diagnostics—But GLP-1 Fallout Looms Hims & Hers used the Super Bowl stage to push its latest offering: a $689 early cancer detection test. It’s a bold move that signals the company’s push into higher-stakes medicine—at a time when it’s already under federal investigation for its compounded weight-loss treatments. Investors see aggressive marketing and topline growth. 2. McKesson’s Portfolio Shake-Up: Can Focused Platforms Deliver Faster, Smarter Expansion? McKesson Corporation’s latest financial report for the third quarter of fiscal year 2026 highlights the company's robust performance, reflecting both the strengths and potential challenges within its operations.

Brief Healthcare: Novartis’ Next Growth Engine—B-Cell Therapies, Autoimmune Breakthroughs, and Massive Unmet Needs! and more

In this briefing: Novartis’ Next Growth Engine—B-Cell Therapies, Autoimmune Breakthroughs, and Massive Unmet Needs! Primer: RPG Life Sciences (RPGL IN) - Feb 2026 Hybridan Small Cap Feast: 2 February 2026 ENP : How Entropy Neurodynamics Is Rethinking Binge Eating Disorder and Pain with IV Psilocin Astellas Pharma (4503 JP): Strategic Brands Gain Further Momentum, Margins Expand, Guidance Revised 1. Novartis’ Next Growth Engine—B-Cell Therapies, Autoimmune Breakthroughs, and Massive Unmet Needs! Novartis, a global healthcare company, released its Q4 and full-year 2025 financial results, highlighting both achievements and challenges. The company posted an 8% growth in full-year sales, driven largely by its priority brands. Core operating income (Core OpInc) increased by 14%, and the company achieved a core margin of 40.1% two years ahead of its target. 2. Primer: RPG Life Sciences (RPGL IN) - Feb 2026 RPG Life Sciences is demonstrating a robust growth trajectory, consistently outperforming the Indian pharmaceutical market, driven by strong performance in its domestic formulations, international formulations, and API segments.

Brief India: PFC - REC: Assessing the Potential Merger and Its Implication for the Shareholders and more

In this briefing: PFC - REC: Assessing the Potential Merger and Its Implication for the Shareholders Primer: RPG Life Sciences (RPGL IN) - Feb 2026 Fractal Analytics IPO: Play on Enterprise AI and Analytics, Quality Franchise at Premium Valuation Scales An Apple a Day—Early Signs of a Healthy FY26 Asian Equities: India - Light at the End of the Tunnel 1. PFC - REC: Assessing the Potential Merger and Its Implication for the Shareholders The merger creates a sovereign-backed powerhouse with a Rs.11.5 trillion loan book to eliminate redundancies and lead India’s energy transition toward the "Viksit Bharat" 2047 vision. Unification removes the 30–35% "holding company discount " on PFC’s stock, streamlining capital raising and improving global borrowing efficiency through a single, massive balance sheet. Combining entities prevents internal competition, optimizes risk management for renewable projects, and allows for massive lending diversification into logistics, smart metering, and EV infrastructure. 2.

Brief Equities Bottom-Up: Primer: Sporton International (6146 TT) - Feb 2026 and more

In this briefing: Primer: Sporton International (6146 TT) - Feb 2026 Primer: Far East Consortium International (35 HK) - Feb 2026 Primer: Zhejiang Sanhua Intelligent Controls (2050 HK) - Feb 2026 Primer: Tipco Asphalt (TASCO TB) - Feb 2026 Primer: RPG Life Sciences (RPGL IN) - Feb 2026 1. Primer: Sporton International (6146 TT) - Feb 2026 Sporton International is a key player in the testing and certification market for wireless communication devices, a sector driven by continuous technological advancement and stringent regulatory standards. The company is navigating a period of financial consolidation, with recent revenue and margin contraction following a strong growth phase. Future performance hinges on capitalizing on emerging technologies like Wi-Fi 7/8, 5G, AI PCs, and expanding into the automotive sector. Valuation appears reasonable relative to global peers, and the company maintains a strong commitment to shareholder returns through a high dividend yield, though the payout has recently seen a slight decrease.

Brief Growth Ideas: Primer: Sporton International (6146 TT) - Feb 2026 and more

Brief Equities Bottom-Up: Primer: Far East Consortium International (35 HK) - Feb 2026 and more

In this briefing: Primer: Far East Consortium International (35 HK) - Feb 2026 Primer: Zhejiang Sanhua Intelligent Controls (2050 HK) - Feb 2026 Primer: Tipco Asphalt (TASCO TB) - Feb 2026 Primer: RPG Life Sciences (RPGL IN) - Feb 2026 Krafton (1 Trillion Won Shareholder Returns Next 3 Years) 1. Primer: Far East Consortium International (35 HK) - Feb 2026 Far East Consortium International Limited (FEC) is a geographically diversified company with a primary focus on property development, hotel operations, and gaming. The company follows an "Asian wallet"strategy, targeting the wealth of Asian consumers across its various business segments and locations. The company is currently undergoing a strategic shift to deleverage its balance sheet and increase its focus on recurring income streams. This involves the disposal of non-core assets and a greater emphasis on its hotel and gaming operations to provide more stable cash flow. Financial performance has been mixed, with recent revenue declines due to fewer property completions, but with an improving trend in adjusted cash profit.

Brief Growth Ideas: Primer: Far East Consortium International (35 HK) - Feb 2026 and more

In this briefing: Primer: Far East Consortium International (35 HK) - Feb 2026 Primer: Zhejiang Sanhua Intelligent Controls (2050 HK) - Feb 2026 Primer: Tipco Asphalt (TASCO TB) - Feb 2026 Primer: RPG Life Sciences (RPGL IN) - Feb 2026 Arta Finance: Scaling the Digital Family Office (Initiation) 1. Primer: Far East Consortium International (35 HK) - Feb 2026 Far East Consortium International Limited (FEC) is a geographically diversified company with a primary focus on property development, hotel operations, and gaming. The company follows an "Asian wallet"strategy, targeting the wealth of Asian consumers across its various business segments and locations. The company is currently undergoing a strategic shift to deleverage its balance sheet and increase its focus on recurring income streams. This involves the disposal of non-core assets and a greater emphasis on its hotel and gaming operations to provide more stable cash flow. Financial performance has been mixed, with recent revenue declines due to fewer property completions, but with an improving trend in adjusted cash profit.

Brief Equities Bottom-Up: Primer: Zhejiang Sanhua Intelligent Controls (2050 HK) - Feb 2026 and more

In this briefing: Primer: Zhejiang Sanhua Intelligent Controls (2050 HK) - Feb 2026 Primer: Tipco Asphalt (TASCO TB) - Feb 2026 Primer: RPG Life Sciences (RPGL IN) - Feb 2026 Krafton (1 Trillion Won Shareholder Returns Next 3 Years) Hybridan Small Cap Feast: 2 February 2026 1. Primer: Zhejiang Sanhua Intelligent Controls (2050 HK) - Feb 2026 Zhejiang Sanhua Intelligent Controls is a global leader in control components for the HVAC&R industry and a key supplier of thermal management systems for New Energy Vehicles (NEVs). The company is strategically positioned to benefit from the dual secular growth trends of global decarbonization: the transition to electric vehicles and the increasing demand for energy-efficient heating and cooling solutions. Strong financial performance, characterized by consistent revenue growth and robust cash flow generation, is underpinned by a commitment to R&D, a global manufacturing footprint, and long-standing relationships with major global OEMs. This content is AI-generated and displayed for general informational purposes only.

Brief Equities Bottom-Up: Primer: Tipco Asphalt (TASCO TB) - Feb 2026 and more

In this briefing: Primer: Tipco Asphalt (TASCO TB) - Feb 2026 Primer: RPG Life Sciences (RPGL IN) - Feb 2026 Krafton (1 Trillion Won Shareholder Returns Next 3 Years) Hybridan Small Cap Feast: 2 February 2026 Systems Engineering Consulta (3741 JP): Q3 FY03/26 flash update 1. Primer: Tipco Asphalt (TASCO TB) - Feb 2026 Tipco Asphalt (TASCO) is a leading manufacturer and distributor of asphalt products in the Asia-Pacific region, with a significant presence in the Thai domestic market. The company's integrated business model includes manufacturing, trading, marine logistics, and road construction services. The company's financial performance is heavily influenced by the volatility of crude oil prices, which is the primary feedstock for asphalt. This exposure leads to fluctuating margins and profitability, as evidenced by the recent decline in net income despite a period of strong performance in 2022 and early 2023. While TASCO offers a compelling dividend yield, its long-term growth metrics for net income and earnings per share have been negative.

RPG Life Sciences Ltd. engages in the development, manufacture, and marketing of pharmaceutical products. It operates in the pharmaceuticals business, offering branded formulations, global generics, and synthetic active pharmaceutical ingredients across therapeutic areas including nephrology, oncology, cardiology, diabetology, urology, respiratory, and pain management. The firm’s product portfolio includes brands such as Aldactone, Serenace, Naprosyn, Azoran, Norpace, and Lomotil. The company was founded in 1968 and is headquartered in Mumbai, India.

Current Price	2,594.40
Prev Close	2,630.00
Open	2,603.20
Dividend Yield	1.30%
50-Day Moving Average	2,787.58
Beta	N/A
Avg. Volume	28,324.09
PE Ratio	39.36

52-Week High	3,127.80
52-Week Low	1,733.00
Market Capitalization	43.17B
EPS (Annual)	69.64
Price to Book	6.27
Revenue Per Employee	3.5M

Feed

News

Sentiment

Fundamentals

Info

RPGLIFE.NSE Fundamentals